Medication vs. Therapy for Depression: What Works Best?

Ask five people whether medication or therapy is the “right” way to treat depression, and you’ll likely get five confident, contradictory answers. The honest answer from the research is less satisfying and more useful: it’s rarely one or the other, and the evidence increasingly points toward combining them.

A 2026 individual participant data meta-analysis pooling 31 randomized trials and more than 3,700 participants found that combined treatment was more effective than medication alone in reducing depressive symptoms at posttreatment, and the advantage persisted at both 6- and 12-month follow-up. That is a meaningfully strong signal, but it isn’t the whole story. What actually works best depends on severity, timeline, and how closely treatment gets monitored, not a single formula that applies to everyone.

What This Page Covers

• What the strongest current evidence says about medication versus therapy
• Why combining them doesn’t cancel out either treatment’s effect
• Where the evidence is more mixed, and what that means practically
• How the two approaches differ in timeline and mechanism
• What actually determines the right choice for a given person

The Strongest Evidence: Combined Treatment

The meta-analysis referenced above is one of the more rigorous comparisons available, because it pooled individual patient data rather than only summary statistics, which allows for a more precise estimate of effect size. The researchers concluded that combined treatment outperforms pharmacotherapy alone regardless of individual patient characteristics, meaning its use does not need to be limited to specific subgroups. In plain terms, no particular type of patient was identified who did better with medication alone than with medication plus therapy.

This matters because it counters a common assumption that combination treatment is only worth the extra time and cost for the most severe cases. The data suggests the benefit is broader than that.

Starting With Therapy Doesn’t Undercut Medication Later

A separate concern people often raise is whether starting with therapy will somehow make medication less effective if it’s added later, or vice versa. A meta-analysis of 300 randomized controlled trials, involving over 32,000 participants, examined this directly and found no significant association between the proportion of patients using antidepressants and the effect size of psychotherapy. The researchers described this as good clinical news, because patients can begin with psychotherapy without needing to worry that doing so will blunt the benefit of medication down the road.

This independence is clinically useful. It means the sequencing question, whether to start with therapy, medication, or both, can be based on access, preference, and severity rather than a fear of undermining a future option.

Where the Evidence Is More Mixed

Combined treatment is not a universal answer, and the research is honest about that. A 2026 pragmatic clinical trial in adolescents with major depressive disorder found that fluoxetine combined with cognitive behavioral therapy showed no significant advantage over fluoxetine monotherapy on the primary response outcome. The trial’s authors noted limitations, including a comparatively small sample and lack of full blinding, so this single result shouldn’t be read as contradicting the broader adult literature. But it is a useful reminder that population, age, and specific outcome measured all shape whether combination adds meaningful benefit in a given case.

The practical takeaway isn’t that combination treatment is oversold. It’s that “combine everything, always” isn’t a substitute for individualized judgment, especially in younger patients or milder presentations where a simpler approach may be just as effective.

How the Two Approaches Actually Differ

Medication and therapy work through different mechanisms, and understanding that difference helps explain why combining them can address more ground than either alone.

Antidepressants, most commonly SSRIs, work by altering neurotransmitter availability in the brain, which can improve biological symptoms like sleep, appetite, and energy over a timeline of roughly four to eight weeks. Therapy, particularly structured approaches like cognitive behavioral therapy, works by changing thought patterns and behavioral responses that maintain depressive symptoms, building skills that tend to reduce relapse risk over a longer horizon rather than producing an immediate biological shift.

Neither mechanism replaces the other. Medication can create enough symptom relief for someone to engage meaningfully in therapy, and therapy can build the coping skills that reduce the odds of relapse after medication is eventually tapered.

What Actually Determines the Right Choice

Severity is one of the clearest guideposts. Moderate to severe depression, especially with significant disruption to sleep, appetite, or energy, tends to respond well to medication as a foundation, often alongside therapy. Milder depression, or depression closely tied to an identifiable stressor or thought pattern, sometimes responds well to therapy alone.

Access and preference matter too. Someone who strongly prefers not to take medication, or who cannot access consistent psychotherapy, still has a real treatment path available; it just may take a different shape.

What matters most in either case is that someone is actually tracking whether the treatment is working, not assuming it is because a prescription was written or a few sessions were attended. Depression that isn’t improving after eight weeks on a stable medication dose, or after a reasonable course of therapy, needs a plan adjustment, not just patience.

About SiggyMD

Siggy provides clinician-supervised care for depression, built around exactly this kind of continuous tracking. Every treatment plan starts with a free, anonymous intake and is reviewed and approved by a licensed prescriber before anything is prescribed, and check-ins between visits mean medication response gets caught and adjusted in days, not at the next quarterly appointment.

“The patients who do best aren’t the ones who picked the ‘correct’ treatment on the first try,” says Daniel Montville, MD, Psychiatrist with the SiggyMD clinical team. “They’re the ones whose care team actually knows whether week six looks different from week one, and adjusts from there instead of waiting three months to ask.”

The intake begins without an account, name, or email. For related reading, see our antidepressants guide.

Start your anonymous intake with SiggyMD.

What Members Are Saying

C.B., 38

Moderate Depression, Combined Treatment

“I’d tried therapy alone twice before and always felt like I was working hard for very little movement. Adding medication didn’t replace the therapy, it just gave me enough energy to actually use what I was learning in sessions. Six months in, the combination made more sense than either had alone.”

T.N., 24

Mild Depression, Therapy Only

“My depression was pretty clearly tied to a specific period of burnout, not something that felt biological. My provider agreed therapy alone made sense to start, with medication as a backup plan if things didn’t move. It worked, and I appreciated not being pushed straight to a prescription.”

Member stories reflect real experiences. Names and identifying details have been changed to protect privacy. Results vary. You can begin anonymous intake without an account, name, email, or payment.

If you are in crisis or experiencing thoughts of self-harm, call or text 988. If you are in immediate danger, call 911.

Sources

1. Ciharova M, Karyotaki E, Harrer M, et al. Modifiers in Effects of Combined Pharmacotherapy and Psychotherapy versus Pharmacotherapy Alone for Adult Depression: An Individual Participant Data Meta-Analysis. Psychotherapy and Psychosomatics. 2026.

2. Cuijpers P, Miguel C, Harrer M, Ciharova M, Karyotaki E. Does the use of pharmacotherapy interact with the effects of psychotherapy? A meta-analytic review. European Psychiatry. 2023;66(1):e63.

3. He Y, Xian Y, Li X, et al. Sequenced treatment alternatives to relieve adolescent depression: A pragmatic clinical trial. Journal of Affective Disorders. 2026;404:121511.

4. National Institute of Mental Health. Depression. NIMH. Reviewed 2024.